Guardant Health
360Dx Index Maintains Steady Ascent, Increasing 3 Percent in August
Of the 29 companies in the index, 18 saw increases in their stock prices, while 11 saw declines.
Guardant Health Laying Path for Future in Cancer Screening, Updates Launch Plans for CRC Assay
Premium
The firm said it will release its colorectal cancer test as an LDT next year and has reorganized its leadership to support future growth in the cancer screening market.
Guardant Health Q2 Revenues Grow 39 Percent
The firm's oncology testing revenues outpaced other revenue sources, driven by a more than 50 percent increase in clinical test volume.
TwinStrand Biosciences Sues Guardant Health for Alleged Patent Infringement
The company argued in its complaint that Guardant's liquid biopsy assays have willfully infringed its patented duplex sequencing technology.
Korean AI Pathology Startup Lunit Nabs $26M Investment from Guardant Health; Plans Collaboration
Having closed a Series C funding round, the firm is completing clinical validation, and will collaborate with Guardant to develop new precision oncology products.
Jun 22, 2021
May 6, 2021
Guardant Health Q1 Revenues up 17 Percent
Feb 24, 2021
Guardant Health Q4 Revenues Up 25 Percent
Feb 5, 2021
Nov 17, 2020
Guardant Health Prices $1B Senior Notes Offering
Nov 5, 2020